Literature DB >> 17637111

Emergency department utilization and success rates for intraosseous infusion in pediatric resuscitations.

C Nijssen-Jordan.   

Abstract

OBJECTIVE: To determine the frequency of use and the success rates of intraosseous (IO) vascular access in the emergency department.
DESIGN: A retrospective chart review.
SETTING: A tertiary pediatric emergency department (ED) in a large urban centre.
METHODS: ED resuscitations (ICD-9 code 996) occurring between Oct. 1, 1989, and Sept. 30, 1995, were identified by searching the ED database, inpatient database, ICU admission log and provincial medical examiner's database. From these, all cases involving IO access were selected and comprised the study sample. Demographics, diagnosis, number of IO attempts, success or failure of IO placement, relevant times and patient outcomes were recorded on standard data forms. Frequency of use, success rates and performance times were reported.
RESULTS: IO access was successful in 36 of 42 (86%) patients. In total, there were 68 attempts, or 1.6 attempts per child. All but one child were less than 3 years of age. The median time to successful IO placement was 8 minutes. Two complications, both fractures, occurred in one patient, a 10-day-old neonate.
CONCLUSIONS: IO success rates were high despite infrequent use.

Entities:  

Year:  2000        PMID: 17637111     DOI: 10.1017/s1481803500004334

Source DB:  PubMed          Journal:  CJEM        ISSN: 1481-8035            Impact factor:   2.410


  3 in total

1.  Guidelines for paediatric emergency equipment and supplies for a physician's office.

Authors:  M Feldman
Journal:  Paediatr Child Health       Date:  2009-07       Impact factor: 2.253

2.  [Not Available].

Authors:  M Feldman
Journal:  Paediatr Child Health       Date:  2009-07       Impact factor: 2.253

3.  Prehospital pediatric emergencies in Austrian helicopter emergency medical service - a nationwide, population-based cohort study.

Authors:  Harald F Selig; Helmut Trimmel; Wolfgang G Voelckel; Michael Hüpfl; Gerhard Trittenwein; Peter Nagele
Journal:  Wien Klin Wochenschr       Date:  2011-06-22       Impact factor: 1.704

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.